The expression of LEP, LEPR, IGF1 and IL10 in obesity and the relationship with microRNAs

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Collares, Renata Viesti A ^a   Salgado Jr , Wilson ^a   Da Cunha Tirapelli, Daniela Pretti ^a   Dos Santos, José Sebastião ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 10; LEPTIN; LEPTIN RECEPTOR; MICRORNA; MICRORNA 143; MICRORNA 145; PROTEIN MIR27A; PROTEIN MIR27B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BARIATRIC SURGERY; CHOLECYSTECTOMY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; LIVER; MALE; OBESITY; OMENTUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SUBCUTANEOUS FAT; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-10; LEPTIN; MALE; MICRORNAS; MIDDLE AGED; OBESITY; RECEPTORS, LEPTIN; YOUNG ADULT;

EID: 84898622908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093512     Document Type: Article

References (50)

1. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365: 1415-1428. (Pubitemid 40523737)
2. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887. (Pubitemid 46024995)
3. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120: 1640-1645.
4. Martins IS, Marinho SP (2003) The potential of central obesity anthropometric indicators as diagnostics tools. Rev Saude Publica 37: 760-767. (Pubitemid 38088162)
5. Vettor R, Milan G, Rossato M, Federspil G (2005) Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 22: 3-10. (Pubitemid 41564373)
6. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, et al. (1999) Role of adiponecytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38: 202-206.
7. Matsuzawa Y, Funahashi T, Nakamura T (2002) Molecular mechanism of vascular disease in the metabolic syndrome X. J Diabetes Complications 16: 17-18. (Pubitemid 34168494)
8. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556. (Pubitemid 38766330)
9. Gnacinska M, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K (2009) Role of adipokines in complications related to obesity: a review. Adv Med Sci 54: 150-157.
10. Wajchenberg BL (2000) Tecido adiposo como glândula endócrina. Arq Bras Endocrinol Metab 44: 13-20.
11. Romero CEM, Zanesco A (2006) The role of leptin and ghrelin on the genesis of obesity. Rev Nutr 19: 85-91.
12. Cleveland-Donovan K, Maile LA, Tsiaras WG, Tchkonia T, Kirkland JL, et al. (2010) IGF-1 activation of the Akt pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology 151: 3752-3763.
13. Grégoire-Nyomba BL, Johnson M, Berard L, Murphy LJ (1999) Relationship between serum leptin and the insulin-like growth factor-1 system in humans. Metabolism 48: 840-844. (Pubitemid 29310036)
14. Esposito K, Pontillo A, Giugliano F, Guigliano G, Marfella R, et al. (2003) Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 88: 1055-1058. (Pubitemid 36337756)
15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and interleukin-10 receptor. Ann Rev Immunol 19: 683-765.
16. Jackson RJ, Standart N (2007) How do MicroRNAs regulate gene expression? Sci STKE 367: 1-14.
17. Lowery AJ, Miller N, McNeill RE, Kerin ML (2008) MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res 14: 360-365. (Pubitemid 351226101)
18. Henegham HM, Miller N, Kerin MJ (2009) Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11: 354-361.
19. Yang W, Lee DY, Ben-David Y (2011) The roles of microRNAs in tumorigenesis and angiogenesis. Int J Physiol Pathophysiol Pharmacol 3: 140-155.
20. Tang X, Muniappan L, Tang G, Ozcan S (2009) Identification of glucoseregulated miRNAs from pancreatic b cells reveals a role of for miR 30-d in insulin transcription. RNA 15: 287-293.
21. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, et al. (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279: 52361-52365. (Pubitemid 39656612)
22. La Rocca G, Shi B, Audia A, Ferrari-Amorotti G, Mellert HS, et al. (2011) Regulation of microRNA-145 by growth arrest and differentiation. Exp Cell Res 317: 488-495.
23. Klöting N, Berthold S, Kovacs P, Schön MR, Fasshauer M, et al. (2009) MicroRNA expression in human omental and subcutaneous adipose tissue. Plos One 4: 4699.
24. Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, et al. (2011) Obesity-induced over expression of miRNA-143 inhibits insulinstimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 13(4): 434-46.
25. Buchwald H & Williams SE (2004) Bariatric surgery worldwide 2003. Obes Surg 14(9): 1157-64. (Pubitemid 39458587)
26. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285: 527-533.
27. Mehta R, Birerdinc A, Hossain N, Afendy A, Chandhoke V, et al. (2010) Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples. BMC Mol Biol 11: 1-10.
28. Kopelman PG (2000) Obesity as a medical problem. Nature 404: 635-643. (Pubitemid 30205068)
29. Gautron L, Elmquist JK (2011) Sixteen years and counting: an update on leptin in energy balance. J Clin Invest 121: 2087-2093.
30. Pardina E, Ferrer R, Baena-Fustequeras JA, Lecube A, Fort JM, et al. (2010) The relationship between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg 20(5): 623-632.
31. Esteghamati A, Noshad S, Khalilzadeh O, Morteza A, Nazeri A, et al. (2011) Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects. Arch Med Res 42: 244-251.
32. Fain JN (2010) Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010: 1-20.
33. Dusserre E, Moulin P, Vidal H (2000) Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500: 88-96. (Pubitemid 29525402)
34. Moses AGW, Dowidar N, Holloway B, Waddell I, Fearon KC, et al. (2001) Leptin and its relation to weigh loss, ob gene expression and the acute-phase response in surgical patients. Br J Surg 88: 588-593. (Pubitemid 32291243)
35. Russel C D, Ricci M R, Brolin RE, Magill E, Fried SK (2001) Regulation of the leptin content of obese human adipose tissue. Am J Physiol Endocrinol Metab 280: 399-404.
36. Schoof E, Stuppy A, Harig F, Carbon R, Horbach T, et al. (2004) Comparison of leptin gene expression in different adipose tissues in children and adults. Eur J Endocrinol 150: 579-584. (Pubitemid 38584710)
37. Ramis JM, Bibiloni B, Moreiro J, García-Sanz JM, Salinas R, et al. (2005) Tissue leptin and plasma insulin are associated with lipoprotein lipase activity in severely obese patients. J Nutr Biochem 16: 279-285. (Pubitemid 41556916)
38. Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, et al. (2008) Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril 89: 642-648. (Pubitemid 351337665)
39. Owecki M, Nikisch E, Miczke A, Pupek-Musialik D, Sowinski J (2010) Leptin, soluble leptin receptors, free leptin index, and their relationship with insulin resistance and BMI: high normal BMI is the threshold for serum leptin increase in humans. Horm Metab Res 42: 585-589.
40. Séron K, Corset L, Vasseur F, Boutin P, Gómez-Ambrosi J, et al. (2006) Distinct impaired regulation of SOC S3 and long and short isoforms of the leptina receptor in visceral and subcutaneous fat of lean and obese women. Biochem Biophys Res Commun 348(4): 1232-8. (Pubitemid 44291338)
41. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, et al. (1997) Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGFbinding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 21: 355-359. (Pubitemid 27190186)
42. Gómez JM, Maravall FJ, Gómez N, Navarro MA, Casamitjana R, et al. (2004) The IGF-1 system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res 14: 91-96. (Pubitemid 38332074)
43. Bassols J, Botas P, Moreno-Navarrete JM, Delgado E, Ortega F, et al. (2010) Environmental and genetic factors influence the relationship between circulating IL-10 and obesity phenotypes. Obesity 18: 611-618.
44. Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, et al. (2006) Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 55: 1529-1533. (Pubitemid 44195398)
45. Siegmund B, Sennello JA, Lehr HA, Batra A, Fedke I, et al. (2004) Development of intestinal inflammation in double IL-10-and leptin-deficient mice. J Leukoc Biol 76: 782-786. (Pubitemid 39313713)
46. van Exel E, Gussekloo J, de Craen AJ, Frölich M, Bootsma-Van Der Wiel A, et al. (2002) Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study. Diabetes 51(4): 1088-92. (Pubitemid 34438354)
47. Kim SY, Kim AY, Lee HW, Son YH, Lee GY, et al. (2010) MiR-27a is a negative regulator of adipocyte differentiation via suppressing PPARc expression. Biochem Biophys Res Commun 392: 323-328.
48. Ortega FJ, Moreno-Navarrete JM, Pardo G, Sabater M, Hummel M, et al. (2010) MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. Plos One 5: 1-9.
49. Ji J, Zhang J, Huang G, Qian J, Wang X, et al. (2009) Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583: 759-766.
50. Takanabe R, Ono K, Abe Y, Takaya T, Horie T, et al. (2008) Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 376: 728-732.